Management team

Siem VAN DER LAAN, PhD

CEO / CSO. Doctor in Biopharmaceutical Sciences.

Siem obtained his PhD in medical pharmacology in 2008 at the University of Leiden, the Netherlands. Entrepreneurial scientist, he contributed to over 25 publications and 6 patents. His career has been in science management in top-end research facilities in Australia, the Netherlands and France. He has conducted research and managed teams in both public research institutes and biotechnology company.

Khaled HACHED, PhD MBA

COO. Doctor in Life Sciences.

Khaled obtained his PhD in biology in 2010 at the University Pierre and Marie Curie, Paris, France. After a post-doctorate in biology and biochemistry at the Centre of Research in Cell Biology of Montpellier, he completed a master in business administration at the University School of Management of Montpellier (IAE). He was previously marketing innovation analyst at Horiba Medical, a world leader of in vitro diagnostics, where he defined commercial value of new medical innovations, and liaised with KOLs to understand unmet needs in clinical care.

Operational team

Guillaume MARCELLIN

Biochemist and bioinformatician

Guillaume is a seasoned protein biochemist trained to microtubule biochemistry in the ‘Tubulin code’ team at the Institute of Human Genetics (IGH) in Montpellier. He masters microtubule (MT) related biochemistry and further developed skills in bio-informatics applied to drug design. Guillaume has over 10 years applied biochemistry expertise and worked in governmental research organizations, SMEs and large companies.

Yoann LANNAY

Molecular and cellular biologist

Yoann is a skilled molecular and cellular biologist trained in academic, hospital and industry settings where he conducted R&D programs and medical analysis for over 10 years. He is trained as microtubule biologist at the Institute of Human Genetics (IGH) in Montpellier and has been key to the initial maturation program. Yoann is knowledgeable in laboratory automation and in implementation of screening methodologies.

Zoé GARISOAIN

Chemical engineer

Zoé is a freshly graduated chemist from the Ecole Nationale Supérieure de Chimie, Biologie et Physique de Bordeaux (ENSCBP). She has multiple professional experience within the pharmaceutical sector both in France and in The Netherlands.

Anthony FERAL

Medicinal chemist

Anthony is a trained medicinal chemist with deep understanding of molecular modelling and compound optimisation. Prior joining MT-act he has been working as a medchem engineer on the development of potent and selective compounds.

Laura QUEYRET

Intern

Laura is an IBIS Master's student at Montpellier University. This training prepares students to work in (i) biology and health research in public and private institutions, or (ii) technical and regulatory professions, healthcare and pharmaceutical biotechnology and clinical trials. This program provides a transdisciplinary training and is supported by the Faculties of Medicine, Pharmacy and Science of the University of Montpellier.

Advisory board

Eric MOUSSAUD-FERGEAU, MSc

Business Development expert

Eric has extensive experience in the life sciences industry, with a strong managerial, scientific, and academic background. He held executive positions in the pharma industry for more than 30 years in marketing, sales management, and business development at national and international level. Eric acted as head of Business Development for Sanofi Europe and was member of the Global Business Development Committee. He managed the Sanofi Pasteur - MSD joint venture Alliance during the launch of Gardasil in Europe. Over his last 15 years working at Sanofi he excelled in diverse business development transactions, including in-licensing, out-licensing and company acquisitions throughout Europe.